Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting results tomorrow afternoon. Here’s what to look for.

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) reported Q4 CY2024 results exceeding the market’s revenue expectations, ...

BOSTON—Ourania Tatsis, Executive Vice President and Chief Regulatory and Quality Officer at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), a $116 billion market cap biotech company currently trading near ...

Google Cloud's revenue grew 30% YoY in Q4'24 with margins up to 17.51%, driven by AI advancements. Discover their $75B ...

Some of the key improvements include: Google has made the model available via Gemini API in Google AI Studio and Vertex AI, making it accessible to developers and businesses looking to integrate ...

Vertex (VRTX) stock was trading largely flat post-market after the company released its Q4 earnings report and issued 2025 ...

Stuart Arbuckle, who’s been with Vertex since 2012, plans to retire from his role in July. His departure comes as Vertex works to build markets for new drugs like Casgevy and Journavx.

Founded in 2017 and headquartered in Bengaluru, SpotDraft offers an AI-powered contract automation platform that assists ...

Vertex Pharmaceuticals ( VRTX) reported fourth-quarter revenue and offered an outlook for 2025 that topped analysts’ expectations. The company said it anticipates 2025 revenue of $11.75 billion to $12 ...

SpotDraft is an AI-driven contract lifecycle management (CLM) platform built for in-house legal teams. The tool manages all aspects of contracting, including AI-assisted redlining, e-signatures, ...

CPI inflation, retail sales, Jerome Powell congressional testimony, along with earnings from Coca-Cola, McDonald’s, Cisco, ...

SpotDraft, a contract lifecycle management platform with AI-powered features, has raised $54 million in a new funding round.